Maven Securities’s Kymera Therapeutics KYMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.18M	Buy	+50,000	New	+$2.18M	0.05%	34
2020 Q4	–	Sell	-7,143	Closed	-$226K	–	620
2020 Q3	$226K	Buy	+7,143	New	+$226K	0.02%	309